Paul T. Kim

Paul T. Kim is principal of Kendall Square Policy Strategies LLC, providing advice on the US Food and Drug Administration (FDA) and life science and public health policy to Fortune 500 companies, national patient advocates, trade associations, and emerging companies in the US, Europe, Israel, and Korea. With expertise and publications in drug and device law, orphan drug innovation, immunization policy, and biodefense matters, he is currently a consultant advisor to the National Organization for Rare Disorders and to the Sjögren’s Foundation. Paul led the FDA and federal government strategy practices at a US law firm for 20 years, following his work as counsel to the late Senator Edward Kennedy, Congressman Henry Waxman, and the late Senator David Pryor. Prior to his work in Congress, Paul worked for the FDA, the American Foundation for AIDS Research, and a European biopharmaceutical company. He earned a J.D. from Georgetown University and a 1990 master’s in public policy from the Kennedy School of Government at Harvard University, and is a 1988 graduate of Harvard College.